Logo do repositório
 
Publicação

Molecular mechanisms controlling the survival and differentiation of human yσ thymocytes

datacite.subject.fosCiências Médicas::Medicina Básicapt_PT
dc.contributor.advisorSantos, Bruno Silva, 1973-
dc.contributor.authorRibeiro, Sérgio Tiago de Freitas, 1989-
dc.date.accessioned2017-07-18T16:53:44Z
dc.date.available2017-07-18T16:53:44Z
dc.date.issued2017
dc.date.submitted2016
dc.descriptionTese de doutoramento, Ciências Biomédicas (Imunologia), Universidade de Lisboa, Faculdade de Medicina, 2017pt_PT
dc.description.abstractAmong the various leukocyte populations that build up the immune defense against infections and tumors, γδ T lymphocytes constitute an enigmatic lineage whose molecular mechanisms of differentiation and activation are still poorly understood. The key roles played by γδ T cells in immunity critically depend on their survival, activation and differentiation into effectors capable of secreting cytokines and killing infected or transformed cells. These processes are controlled, at the molecular level, by surface receptors that capture key extracellular cues and convey downstream intracellular signals that regulate both lymphocyte physiology and pathology. In this PhD thesis we evaluated the contribution of cell receptor signaling pathways to human γδ T cell differentiation and activation. Firstly, we showed that human γδ thymocytes are functionally immature and their differentiation program requires additional IL-2 or IL-15 signals to drive their differentiation into IFN-γ and TNF-α producers endowed with potent cytotoxicity against leukemia targets. We further elucidated the signals involved in normal/ healthy γδ T cell maintenance as well as in γδ T cell tumorigenesis. We identified that the protein kinase CK2 (Casein Kinase 2) is overactivated in the γδ T cell lineage compared to αβ counterparts. We further showed that the clinical grade-inhibitor of CK2, CX- 4945, impairs γδ T cell survival by inhibiting the CK2/AKT/mTOR/GSK3β signaling pathway. Moreover, we showed that CK2 is hyperactivated in γδ T acute lymphoblastic leukemia (T-ALL) samples, compared to both normal γδ T cells and αβ T-ALL. Importantly, we demonstrated a high sensitivity of γδ T-ALL cells to CX- 4945 treatment in vitro and in vivo, thus supporting the use of CK2 inhibitors as a putative therapy for γδ T-ALL. Overall, the data presented in this thesis provided new evidences indicating that: (i) human γδ thymocytes are functionally immature and require IL-2 or IL-15 to differentiate into type 1 cytotoxic effector lymphocytes; (ii) the protein kinase CK2 is a novel determinant of both healthy and leukemic γδ T cell survival; and (iii) the CX-4945 chemical inhibitor is a promising therapeutic approach for γδ T-ALL.pt_PT
dc.description.sponsorshipEuropean Research Council (ERC); Excellence in Life Sciences (EMBO); Foundation Arc Pour Sur Le Cancer; Sociedade Portuguesa de Imunologia; European Federation of Immunological Societies (EFIS); Gabinete de Apoio à Investigação Científica Tecnológica e Inovação (GAPIC)pt_PT
dc.identifier.tid101523246pt_PT
dc.identifier.urihttp://hdl.handle.net/10451/28402
dc.language.isoengpt_PT
dc.relationINTEGRATION OF RECEPTOR SIGNALING PATHWAYS IN THE DIFFERENTIATION AND FUNCTIONAL ACTIVATION OF HUMAN T LYMPHOCYTES
dc.subjectLinfócitos T γδpt_PT
dc.subjectDiferenciação de células Tpt_PT
dc.subjectLeucemia linfoblástica agudapt_PT
dc.subjectVias de sinalizaçãopt_PT
dc.subjectProteína cinase CK2pt_PT
dc.subjectTeses de doutoramento - 2017pt_PT
dc.titleMolecular mechanisms controlling the survival and differentiation of human yσ thymocytespt_PT
dc.typedoctoral thesis
dspace.entity.typePublication
oaire.awardNumberSFRH/BD/84123/2012
oaire.awardTitleINTEGRATION OF RECEPTOR SIGNALING PATHWAYS IN THE DIFFERENTIATION AND FUNCTIONAL ACTIVATION OF HUMAN T LYMPHOCYTES
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F84123%2F2012/PT
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typedoctoralThesispt_PT
relation.isProjectOfPublication65931289-f3e0-4c8a-8d8e-9b35cfdbb22d
relation.isProjectOfPublication.latestForDiscovery65931289-f3e0-4c8a-8d8e-9b35cfdbb22d
thesis.degree.nameDoutoramento em Ciências Biomédicaspt_PT

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
ulsd7307707_td_Sergio_Ribeiro.pdf
Tamanho:
19.38 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: